Chemotherapy Agents
Sponsors
National Taiwan University Hospital, Takeda, Kochi University
Conditions
LeukemiaPancreatic Cancer MetastaticPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)Ph+ Mixed Phenotype Acute Leukemia (MPAL)Philadelphia Chromosome-Like ALL (Ph-like ALL)Refractory Lupus NephritisRefractory Systemic SclerosisRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Phase 1
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
TerminatedNCT04501614
Start: 2021-02-24End: 2024-07-19Updated: 2025-10-02
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
TerminatedNCT05886491
Start: 2023-07-11End: 2025-11-30Updated: 2026-04-01
A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)
WithdrawnNCT06377228
Start: 2025-06-13End: 2030-09-02Updated: 2025-04-06
Phase 2
Unknown Phase
Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease
NCT00166790
Start: 2005-09-30End: 2014-12-31Target: 30Updated: 2014-12-08
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
CompletedNCT06921252
Start: 2010-01-01End: 2025-03-01Updated: 2025-04-10